Toggle light / dark theme

As they increasingly log on from home, Americans are having to meld their personal technology with professional tools at unprecedented scale. For employers, the concern isn’t just about capacity, but also about workers introducing new potential vulnerabilities into their routine — whether that’s weak passwords on personal computers, poorly secured home WiFi routers, or a family member’s device passing along a computer virus.


The dramatic expansion of teleworking by US schools, businesses and government agencies in response to the coronavirus is raising fresh questions about the capacity and security of the tools many Americans use to connect to vital workplace systems and data.

At one major US agency, some officials have resorted to holding meetings on iPhone group calls because the regular conference bridges haven’t always been working, according to one federal employee. But the workaround has its limits: The group calls support only five participants at a time, the employee noted.

“Things have worked better than I anticipated, but there are lots of hiccups still,” said the employee, who spoke on condition of anonymity because he is not authorized to speak on the record.

Possible treatments for coronavirus:

Remdesivir by the firm Gilead was developed to fight other viruses including Ebola (where it was shown to be ineffective) and it hasn’t yet been approved for treating anything. Still, it has shown early promise in treating some coronavirus patients in China, according to doctors, and manufacturer Gilead is moving ahead with final stage clinical trials in Asia. It has also been used to treat at least one US patient so far.

NIH’s Anthony Fauci, one of the top government scientists overseeing the coronavirus response, has said it could be available in the next “several months.”


WHO officials says progress being made, but any immunizing solution will take time: ‘There is only one thing more dangerous than a bad virus, and that’s a bad vaccine’

“The Justice Department has quietly asked Congress for the ability to ask chief judges to detain people indefinitely without trial during emergencies — part of a push for new powers that comes as the coronavirus spreads through the United States.”


Coronavirus

One of the requests to Congress would allow the department to petition a judge to indefinitely detain someone during an emergency.

ZURICH (Reuters) — Switzerland’s health care system could collapse by the end of the month if the new coronavirus keeps spreading at current rates, a government official warned on Tuesday.

Swiss authorities estimated that 2,650 people had tested positive for the coronavirus and said 19 people had died, while predicting cases will likely soar in the weeks ahead.

Exact figures were unavailable. Daniel Koch, head of the Federal Office of Health’s communicable diseases division, said the rapid rise had outstripped the state’s ability to record new cases in real time.

Sam Harris discusses the coronavirus withAmesh Adalja.


In this episode of the podcast, Sam Harris speaks with Amesh Adalja about the spreading coronavirus pandemic. They discuss the contagiousness of the virus and the severity of the resultant illness, the mortality rate and risk factors, vectors of transmission, how long coronavirus can live on surfaces, the importance of social distancing, possible anti-viral treatments, the timeline for a vaccine, the importance of pandemic preparedness, and other topics.

Amesh Adalja, MD, is an infectious disease specialist at the Johns Hopkins University Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. Amesh has served on US government panels tasked with developing guidelines for the treatment of plague, botulism, and anthrax. He is an Associate Editor of the journal Health Security, co-editor of the volume Global Catastrophic Biological Risks, and a contributing author for the Handbook of Bioterrorism and Disaster Medicine. Amesh actively practices infectious disease, critical care, and emergency medicine in the Pittsburgh metropolitan area.

Website: www.trackingzebra.com

Twitter: @AmeshAA

SUBSCRIBE to continue listening and gain access to all content on samharris.org/subscribe

Follow Sam on Twitter: https://twitter.com/samharrisorg

On Thursday, March 18, Austin-based Everlywell announced that it will begin selling home tests for COVID-19 beginning Monday, March 23. The business already offers dozens of at-home testing kits for anything from cholesterol levels to fertility to food sensitivities, but it is the first U.S. company to announce an at-home COVID-19 test. Everlywell has an initial supply of 30,000 COVID-19 tests and is working with multiple laboratories to scale that number to 250,000 tests weekly.

The test can be requested online for people experiencing COVID-19 symptoms. To access a test, consumers can go to everlywell.com and complete a screening questionnaire. According to the website, the test is shipped to customers with everything needed to collect a sample at home and safely ship that sample to a CLIA-certified lab partner. (All of Everywell’s laboratory partners conducting COVID-19 testing are complying with the FDA’s Emergency Use Authorization for COVID-19 symptoms.) The samples will then be shipped to partner labs overnight, and secure digital results will be available online within 48 hours of the lab receiving the sample. Free telehealth consultations with an independent, board-certified physician will also be available to those with positive results. The test is $135, at no profit to Everlywell, and is covered by participating HSA and FSA providers. The brand has reached out to government officials to see if the test can be made available for free.

Intel Corp. is releasing an experimental research system for neuromorphic computing, a cutting-edge method that simulates the way human brains work to perform computations faster, using significantly less energy.

The system, called Pohoiki Springs, will be made available this month over the cloud to members of the Intel Neuromorphic Research Community, which includes academic researchers, government labs and about a dozen companies such as Accenture PLC and Airbus SE.

Others, including International Business Machines Corp., are also researching the technique.

U.S. Treasury Secretary Steven Mnuchin said he supports direct payments of $1,000 per adult and $500 per child to Americans within three weeks if Congress backs the plan.

“The president is determined that we are going to support” those affected, Mnuchin said in a Fox Business interview Thursday morning.

Cash handouts to all American households are gaining support in Congress as the best way to shore up an economy brought to a near-standstill by the coronavirus response.

In 2018, Putin approved a national research strategy that stretches to 2024. It calls for more money, extra support for early-career scientists, and some 900 new laboratories, including at least 15 world-class research centres with a focus on mathematics, genomics, materials research and robotics. Last year, the government completed a sweeping evaluation of scientific performance at its universities and institutes; it has vowed to modernize equipment in the 300 institutes that made the top quartile. And it says it wants to strengthen previously neglected areas, including climate and environmental research (see ‘Russia’s climate-science ambitions’).


Some researchers see promise in planned reforms.